# ANAVEX LIFE SCIENCES CORP. (AVXL) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ANAVEX LIFE SCIENCES CORP.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AVXL/mda/fy2025/): filed 2025-11-25; accession 0001731122-25-001596 (https://www.sec.gov/Archives/edgar/data/1314052/000173112225001596/e7052_10-k.htm); latest 10-K
- [FY 2024 MD&A](/company/AVXL/mda/fy2024/): filed 2024-12-23; accession 0001731122-24-002041 (https://www.sec.gov/Archives/edgar/data/1314052/000173112224002041/e6219_10-k.htm)
- [FY 2023 MD&A](/company/AVXL/mda/fy2023/): filed 2023-11-27; accession 0001731122-23-002197 (https://www.sec.gov/Archives/edgar/data/1314052/000173112223002197/e5240_10k.htm)
- [FY 2022 MD&A](/company/AVXL/mda/fy2022/): filed 2022-11-28; accession 0001731122-22-002062 (https://www.sec.gov/Archives/edgar/data/1314052/000173112222002062/e4251_10k.htm)
- [FY 2021 MD&A](/company/AVXL/mda/fy2021/): filed 2021-11-24; accession 0001731122-21-002062 (https://www.sec.gov/Archives/edgar/data/1314052/000173112221002062/e3306_10-k.htm)

Back to /company/AVXL/